POELLATH advises SHS Capital on the launch of its new healthcare private equity fund SHS VI

Founded in 1993, industry investor SHS is a private equity provider that makes investments in healthcare companies in Europe.

The focus of the investments is on expansion financing, change in shareholders and succession affairs. “Building European Healthcare Champions” is the investment philosophy according to which SHS finances and develops portfolio companies. In doing so, the German investor takes both minority and majority stakes. The equity or equity-like investment of the AIF is up to EUR 40 million. Volumes greater than this can be realized with a network of co-investors. In its investment decisions, SHS places strong emphasis on the consideration of ESG aspects and is thus committed to the guidelines of the UN PRI. The investor base comprises private and institutional investor groups with a long-term focus, including well-known family offices, pension funds, provident funds, fund of funds, banks/savings banks, churches, health insurance companies and industrial companies. It also includes the European Investment Fund (EIF) and KfW.

POELLATH advised the management of SHS on all contractual, tax and regulatory aspects of the fund structuring, contract documentation and negotiations with domestic and foreign investors with the following Berlin team:

• Amos Veith (partner, lead, private funds, tax)
• Dr. Robert Eberius (counsel, private funds, tax)
• Michelle Kos-Kogos (associate, private funds, tax)
• Pascal Erler (associate, private funds, tax)

POELLATH previously advised SHS on its predecessor fund.